GA
CME icon

GFS Advisors’s CME Group CME Stock Holding History

GFS Advisors’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,440
Closed -$46K – 125
2024
Q2 		$46K Buy
+40,440
New +$8.36M 0.01% 172

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

GFS Advisors's CME Position: Q3 2024 in Review

GFS Advisors sold out of CME Group (CME) in Q3 2024, closing a stake of 40,440 shares — an estimated $46K sold.

GFS Advisors first reported a position in CME in Q2 2024 and held it in 1 quarter. The position peaked at $46K in Q2 2024. 1,393 funds tracked by Wall St. Rank hold CME as of Q3 2024.

  • GFS Advisors reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
  • GFS Advisors sold 40,440 CME Group shares in Q3 2024, an estimated $46K.
  • GFS Advisors first reported a position in CME Group in Q2 2024 and held it in 1 quarter.
  • GFS Advisors's CME Group position peaked at $46K in Q2 2024.
  • 1,393 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on GFS Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.